CYP2E1-mediated metabolism can produce ROS, which can promote ALD [23,24,25,26] and non-alcoholic fatty liver disease (NAFLD) [27,28]. Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.